Eton Pharmaceuticals Inc (ETON) Insider Trading
- $3,072,235.00
- $17,376,929.41
- Sept. 22, 2022
- Opaleye Management Inc.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 22, 2022 | CEO | 10,000 | $2.10 | Buy | $21,000.00 | |
| Nov. 17, 2021 | Major Shareholder | 25,000 | $4.67 | Sell | $116,750.00 | |
| Nov. 15, 2021 | Major Shareholder | 3,000 | $4.80 | Sell | $14,400.00 | |
| Nov. 8, 2021 | Major Shareholder | 52,661 | $6.10 | Sell | $321,232.10 | |
| Nov. 5, 2021 | Major Shareholder | 167,701 | $6.30 | Sell | $1,056,516.30 | |
| Nov. 3, 2021 | Major Shareholder | 116,500 | $6.53 | Sell | $760,745.00 | |
| Oct. 11, 2021 | Major Shareholder | 34,101 | $5.01 | Sell | $170,846.01 | |
| Oct. 8, 2021 | Major Shareholder | 43,692 | $5.00 | Sell | $218,460.00 | |
| Aug. 6, 2021 | Major Shareholder | 345,000 | $5.84 | Sell | $2,014,800.00 | |
| Aug. 4, 2021 | Major Shareholder | 104,000 | $5.75 | Sell | $598,000.00 | |
| June 3, 2021 | CEO | 5,000 | $5.96 | Buy | $29,800.00 | |
| May 27, 2021 | Major Shareholder | 126,000 | $8.49 | Sell | $1,069,740.00 | |
| May 25, 2021 | Major Shareholder | 48,000 | $8.53 | Sell | $409,440.00 | |
| April 12, 2021 | Major Shareholder | 1,518,000 | $7.00 | Sell | $10,626,000.00 | |
| Oct. 16, 2020 | Major Shareholder | 400,000 | $7.00 | Buy | $2,800,000.00 | |
| Aug. 13, 2019 | CEO | 5,000 | $6.15 | Buy | $30,750.00 | |
| Aug. 9, 2019 | Director | 3,500 | $6.11 | Buy | $21,385.00 | |
| May 21, 2019 | CEO | 10,000 | $7.93 | Buy | $79,300.00 | |
| Nov. 15, 2018 | CEO | 10,000 | $6.00 | Buy | $60,000.00 | |
| Nov. 15, 2018 | CFO | 5,000 | $6.00 | Buy | $30,000.00 |
Insiders are both buying and selling Eton Pharmaceuticals Inc stock.
The insider traders at Eton Pharmaceuticals Inc are: Opaleye Management Inc., Sean Brynjelsen, Charles J Casamento, Harrow Health, Inc., and William Wilson Troutman
The most active insider trader at Eton Pharmaceuticals Inc is Opaleye Management Inc. with 12 trades.
Harrow Health, Inc. has sold the most Eton Pharmaceuticals Inc stock with a total value of $21,252,000.00.
Opaleye Management Inc. has bought the most Eton Pharmaceuticals Inc stock with a total value of $5,600,000.00.
The most recent insider trade for Eton Pharmaceuticals Inc was on Sept. 22, 2022.
The single biggest insider buy for Eton Pharmaceuticals Inc was from Opaleye Management Inc. with a total value of $2,800,000.00 on Oct. 16, 2020.
The single biggest insider sell for Eton Pharmaceuticals Inc was from Harrow Health, Inc. with a total value of $10,626,000.00 on April 12, 2021.